acetylsalicylic acid lysinate has been researched along with Diabetes Mellitus, Type 2 in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Amin, T; Boyce, JA; Cahill, KN; Feng, C; Foer, D; Hayashi, H; Lai, J; Laidlaw, TM; Lin, A; Liu, T; McGill, A; Nagai, J; Newcomb, DC; Niswender, KD; Snyder, WE; Tani, Y | 1 |
| Beggiato, E; Bisi, M; Dosio, E; Gaita, F; Grimaldi, R; Lococo, MF; Lonni, E; Presutti, DG; Tagliabue, M; Valpreda, A | 1 |
| Ceriello, A; D'Onofrio, F; Giugliano, D; Paolisso, G; Quatraro, A; Saccomanno, F | 1 |
| Ceriello, A; D'Onofrio, F; Di Pinto, P; Giugliano, D; Passariello, N; Saccomanno, F | 1 |
1 trial(s) available for acetylsalicylic acid lysinate and Diabetes Mellitus, Type 2
| Article | Year |
|---|---|
Laboratory aspirin resistance reversibility in diabetic patients: a pilot study using different pharmaceutical formulations.
Topics: Aged; Aspirin; Chemistry, Pharmaceutical; Diabetes Mellitus, Type 2; Drug Resistance; Female; Humans; Laboratories; Lysine; Male; Middle Aged; Pilot Projects; Platelet Aggregation; Platelet Aggregation Inhibitors | 2014 |
3 other study(ies) available for acetylsalicylic acid lysinate and Diabetes Mellitus, Type 2
| Article | Year |
|---|---|
Glucagon-like Peptide-1 Receptor Pathway Attenuates Platelet Activation in Aspirin-Exacerbated Respiratory Disease.
Topics: Animals; Aspirin; Asthma; Asthma, Aspirin-Induced; Diabetes Mellitus, Type 2; Glucagon-Like Peptide-1 Receptor; Humans; Inflammation; Interleukin-33; Liraglutide; Mice; Platelet Activation; Prospective Studies; Receptors, Thromboxane | 2023 |
Effects of salicylate, tolbutamide, and prostaglandin E2 on insulin responses to glucose in noninsulin-dependent diabetes mellitus.
Topics: Adult; Aspirin; Blood Glucose; Diabetes Mellitus, Type 2; Dinoprostone; Drug Interactions; Glucose; Humans; Insulin; Lysine; Middle Aged; Prostaglandins E; Tolbutamide | 1985 |
Impaired insulin secretion in human diabetes mellitus. Interactions between naloxone, phentolamine and lysine acetylsalicylate upon glucose induced insulin release.
Topics: Adult; Analgesics; Aspirin; Blood Glucose; Diabetes Mellitus, Type 2; Drug Interactions; Glucose; Humans; Insulin; Insulin Secretion; Kinetics; Lysine; Middle Aged; Naloxone; Phentolamine | 1985 |